B Acute Lymphoblastic Leukemia — Trials

B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

345 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 151
Recruiting: 94
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 51–100 of 345 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03488225	Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia	terminated	Phase 2	4	M.D. Anderson Cancer CenterOTHER	1	Jul 30, 2026	clinicaltrials
NCT03914625	A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia	active not recruiting	Phase 3	6,720	National Cancer Institute (NCI)NIH	5	Jul 30, 2026	clinicaltrials